Viability of intraperitoneal free cancer cells in patients with gastric cancer - PubMed (original) (raw)
. 1982 Sep-Oct;26(5):681-7.
- PMID: 6959458
Viability of intraperitoneal free cancer cells in patients with gastric cancer
O Tanida et al. Acta Cytol. 1982 Sep-Oct.
Abstract
The viability and morphologic changes of intraperitoneal free cancer cells in advanced gastric cancer patients were examined by Giemsa and enzymologic staining and by tritiated thymidine uptake. Although many free cancer cells in the pouch of Douglas showed moderate degeneration, viable, morphologically intact cells were noted, leading to the possibility of their implantation and proliferation in the peritoneum. Serosal cancer cells showed a high degree of viability. In patients undergoing gastric cancer surgery, the viability of free cancer cells was markedly decreased by a single intraoperative administration of 10 mg of mitomycin C (MMC) to the pouch of Douglas, suggesting that this may represent an effective means of preventing peritoneal dissemination.
Similar articles
- Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer.
Ikeguchi M, Oka A, Tsujitani S, Maeta M, Kaibara N. Ikeguchi M, et al. Anticancer Res. 1994 Sep-Oct;14(5B):2131-4. Anticancer Res. 1994. PMID: 7840512 - Intraperitoneal free cancer cells and their viability in gastric cancer.
Iitsuka Y, Kaneshima S, Tanida O, Takeuchi T, Koga S. Iitsuka Y, et al. Cancer. 1979 Oct;44(4):1476-80. doi: 10.1002/1097-0142(197910)44:4<1476::aid-cncr2820440442>3.0.co;2-r. Cancer. 1979. PMID: 498022 - [The prevention of peritoneal dissemination of gastric cancer with intraperitoneal activated carbon particles absorbing mitomycin C].
Ohgaki M, Imanishi T, Ohyama T, Tsujimoto H, Ozaki K, Chohei S, Shimotsuma M, Hagiwara A, Takahashi T. Ohgaki M, et al. Gan To Kagaku Ryoho. 1994 Sep;21(13):2320-2. Gan To Kagaku Ryoho. 1994. PMID: 7944469 Clinical Trial. Japanese. - [Pharmacokinetic analysis in intraperitoneal hyperthermic perfusion using mitomycin C in far-advanced gastric cancer].
Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi S, Ohta M, Takahashi M, Konno C, Koike S, Okui K. Fujimoto S, et al. Gan To Kagaku Ryoho. 1989 Jul;16(7):2411-5. Gan To Kagaku Ryoho. 1989. PMID: 2502075 Japanese. - Peritoneal cytology in the surgical evaluation of gastric carcinoma.
Hayes N, Wayman J, Wadehra V, Scott DJ, Raimes SA, Griffin SM. Hayes N, et al. Br J Cancer. 1999 Feb;79(3-4):520-4. doi: 10.1038/sj.bjc.6690081. Br J Cancer. 1999. PMID: 10027323 Free PMC article.
Cited by
- Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer.
Yu W, Whang I, Suh I, Averbach A, Chang D, Sugarbaker PH. Yu W, et al. Ann Surg. 1998 Sep;228(3):347-54. doi: 10.1097/00000658-199809000-00007. Ann Surg. 1998. PMID: 9742917 Free PMC article. Clinical Trial. - Prognostic significance of intraperitoneal free cancer cells in gastric cancer patients.
Koga S, Kaibara N, Iitsuka Y, Kudo H, Kimura A, Hiraoka H. Koga S, et al. J Cancer Res Clin Oncol. 1984;108(2):236-8. doi: 10.1007/BF00402474. J Cancer Res Clin Oncol. 1984. PMID: 6470030 - When is curative gastrectomy justified for gastric cancer with positive peritoneal lavage cytology but negative macroscopic peritoneal implant?
Miyashiro I, Takachi K, Doki Y, Ishikawa O, Ohigashi H, Murata K, Sasaki Y, Imaoka S, Nakaizumi A, Takenaka A, Furukawa H, Hiratsuka M. Miyashiro I, et al. World J Surg. 2005 Sep;29(9):1131-4. doi: 10.1007/s00268-005-7703-6. World J Surg. 2005. PMID: 16086213 - Spilled cells, spilled clips, spilled stones. New problems or old challenges.
Birkett DH. Birkett DH. Surg Endosc. 1995 Mar;9(3):269-71. doi: 10.1007/BF00187766. Surg Endosc. 1995. PMID: 7597596 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Medical